
Balderton leads $10m series-A for Kaia Health
Balderton Capital has led a $10m series-A funding round for back pain management application Kaia Health.
The VC firm drew capital for the investment from its $375m fund, Balderton VI, which held a final close in November 2017.
The fresh capital will be used to support Kaia's roll-out in the US, including a new office in New York, and fund further clinical studies.
Company
Kaia was founded in 2016 and is headquartered in Munich. It develops a smartphone app that offers daily exercises and relaxation techniques for people with back pain. It has 250,000 users and is used by health insurance companies such as Barmer, which offers the service to its members for free. The company employs 23 people across its operations in Munich and New York.
People
Balderton Capital – James Wise (partner).
Kaia Health – Konstantin Mehl (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater